BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36614238)

  • 1. Transcriptional Regulation of Siglec-15 by ETS-1 and ETS-2 in Hepatocellular Carcinoma Cells.
    Sheng K; Wu Y; Lin H; Fang M; Xue C; Lin X; Lin X
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region.
    Katabami K; Mizuno H; Sano R; Saito Y; Ogura M; Itoh S; Tsuji T
    Clin Exp Metastasis; 2005; 22(7):539-48. PubMed ID: 16475024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.
    Ren X; Ji Y; Jiang X; Qi X
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
    Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
    Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma.
    Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J
    BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
    Xiao R; Tian Y; Zhang J; Li N; Qi M; Liu L; Wang J; Li Z; Zhang J; Zhao F; Wang T; Tan S; Li C; Wu Z; Yu M; Jiang X; Zhan P; Gao L; Han B; Liu X; Liang X; Ma C
    J Hepatol; 2024 May; 80(5):792-804. PubMed ID: 38331327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEF2 transcription factors promotes EMT and invasiveness of hepatocellular carcinoma through TGF-β1 autoregulation circuitry.
    Yu W; Huang C; Wang Q; Huang T; Ding Y; Ma C; Ma H; Chen W
    Tumour Biol; 2014 Nov; 35(11):10943-51. PubMed ID: 25087096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme oxygenase-1/carbon monoxide axis suppresses transforming growth factor-β1-induced growth inhibition by increasing ERK1/2-mediated phosphorylation of Smad3 at Thr-179 in human hepatocellular carcinoma cell lines.
    Park SJ; Lee SK; Lim CR; Park HW; Liu F; Kim SJ; Kim BC
    Biochem Biophys Res Commun; 2018 Apr; 498(3):609-615. PubMed ID: 29524413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma.
    Guo L; Li H; Fan T; Ma Y; Wang L
    Life Sci; 2021 Aug; 279():119359. PubMed ID: 33753114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA TUG1 Inhibits Tumor Progression through Regulating Siglec-15-Related Anti-Immune Activity in Hepatocellular Carcinoma.
    Ren Y; Lyu J; Guo Y; Yao Y; Hu L
    J Immunol Res; 2022; 2022():9557859. PubMed ID: 35237695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β1 gene expression in hepatocellular carcinoma: a preliminary report.
    Farid IM; Hamza IM; El-Abd DM; Mohyi AM; AbdulLatif MM; Aref AT; Hamza DM
    Arab J Gastroenterol; 2014; 15(3-4):142-7. PubMed ID: 25475758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.
    Tao L; Wang S; Yang L; Jiang L; Li J; Wang X
    Clin Exp Immunol; 2020 Aug; 201(2):161-170. PubMed ID: 32319079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
    Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
    BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
    Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling.
    Feng XX; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Tian DA
    PLoS One; 2013; 8(11):e79857. PubMed ID: 24260309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ERK1/2 Signaling Impairs the Promoting Effects of TGF-β1 on Hepatocellular Carcinoma Cell Invasion and Epithelial-Mesenchymal Transition.
    Liu L; Li N; Zhang Q; Zhou J; Lin L; He X
    Oncol Res; 2017 Nov; 25(9):1607-1616. PubMed ID: 28492136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.